0001293973-13-000001.txt : 20130305 0001293973-13-000001.hdr.sgml : 20130305 20130305183859 ACCESSION NUMBER: 0001293973-13-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130301 FILED AS OF DATE: 20130305 DATE AS OF CHANGE: 20130305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ehrlich Christopher B CENTRAL INDEX KEY: 0001293973 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51934 FILM NUMBER: 13667603 MAIL ADDRESS: STREET 1: C/O INTERWEST PARTNERS STREET 2: 2710 SAND HILL ROAD, 2ND FLOOR CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMIMETIC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001138400 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 621786244 STATE OF INCORPORATION: DE FISCAL YEAR END: 1211 BUSINESS ADDRESS: STREET 1: 389-A NICHOL MILL LANE CITY: FRANKLIN STATE: TN ZIP: 37067 BUSINESS PHONE: 615 844 1280 MAIL ADDRESS: STREET 1: 389-A NICHOL MILL LANE CITY: FRANKLIN STATE: TN ZIP: 37067 FORMER COMPANY: FORMER CONFORMED NAME: BIOMIMETIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010413 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2013-03-01 1 0001138400 BIOMIMETIC THERAPEUTICS, INC. BMTI 0001293973 Ehrlich Christopher B C/O INTERWEST PARTNERS 2710 SAND HILL ROAD, 2ND FLOOR MENLO PARK CA 94025 1 0 0 0 Common Stock 2013-03-01 4 D 0 1250 D 0 D Common Stock 2013-03-01 4 D 0 941177 D 0 I By: InterWest Management Partners X, LLC Common Stock 2013-03-01 4 D 0 857692 D 0 I By: InterWest Management Partners VIII, LLC Common Stock 2013-03-01 4 D 0 6846 D 0 I By: InterWest Management Partners VIII, LLC Common Stock 2013-03-01 4 D 0 24538 D 0 I By: InterWest Management Partners VIII, LLC Stock Option (right to buy) 17.09 2013-03-01 4 D 0 5831 0 D 2017-06-21 Common Stock 5831 0 D Stock Option (right to buy) 11.64 2013-03-01 4 D 0 8840 0 D 2018-06-19 Common Stock 8840 0 D Disposed of pursuant to the Agreement and Plan of Merger ("Merger Agreement") dated as of November 19, 2012, by and among the Company, Wright Medical Group, Inc. ("Wright"), Achilles Merger Subsidiary, Inc. and Achilles Acquisition Subsidiary, LLC in exchange for the following merger consideration per share of the Company's common stock: (a) $1.50 in cash, without interest; (b) 0.2482 of a share of Wright's common stock; and (c) one contingent value right ("CVR") issued by Wright. The Reporting Person is a Member of InterWest Management Partners X, LLC, the General Partner of InterWest Partners X, LP ("IW10"). IW10 owns 941,177 shares of BMTI Common Stock. The Reporting Person disclaims beneficial ownership of the shares held by IW10 except to the extent of his pecuniary interest therein. The Reporting Person is a Member of InterWest Management Partners VIII, LLC, the General Partner of InterWest Partners VIII, LP ("IW8"), InterWest Investors VIII, LP ("II8"), and InterWest Investors Q VIII, LP ("IIQ8"). IW8 owns 857,692 shares of BMTI Common Stock, II8 owns 6,846 shares of BMTI Common Stock, and IIQ8 owns 24,538 shares of BMTI Common Stock (together "The IW Fund Holdings"). The Reporting Person disclaims beneficial ownership of The IW Fund Holdings except to the extent of his pecuniary interest therein. Option canceled. Pursuant to the Merger Agreement, the reporting person entered into an agreement with the issuer to terminate stock options with an exercise price greater than $13.00. Pursuant to the Merger Agreement, the stock options granted by the issuer converted into options to purchase 4,613 shares of Wright common stock at an exercise price of $22.31 per share. /s/ Christopher B. Ehrlich 2013-03-05